FDA — authorised 17 April 2020
- Application: NDA213411
- Marketing authorisation holder: SEAGEN
- Local brand name: TUKYSA
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Tukysa in United States
FDA authorised Tukysa on 17 April 2020
Marketing authorisations
FDA
- Status: approved
Tukysa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Tukysa approved in United States?
Yes. FDA authorised it on 17 April 2020; FDA has authorised it.
Who is the marketing authorisation holder for Tukysa in United States?
SEAGEN holds the US marketing authorisation.